Novembre 2022

Aderenza terapeutica e costi sanitari diretti in pazienti in trattamento con terapia antiretrovirale: analisi su dati real-world in Italia

PCSK-9 inhibitors for the control of hypercholesterolemia: elegibility for treatment, prescription appropriateness and outcomes, in a real-world clinical setting

Drug discontinuation and healthcare cost evaluation in Crohn’s disease patients under biologic therapy: an italian retrospective analysis

Epidemiology, patients’ characteristics and healthcare costs in early-stage non-small-cell lung carcinoma: a real-world analysis in Italy

Real-World Analysis of Adherence, Outcomes and Healthcare Costs of Patients Under Quadruple Combination of Antihypertensives in Italy

Do Triple Single-Pill Combinations Make a Difference in Treatment Adherence,
Outcomes and Healthcare Resource Utilization in Hypertension? A Real-World Analysis of Patients on Perindopril/Indapamide/Amlodipine in Italy

HEALTHCARE RESOURCE CONSUMPTION AND RELATED COSTS IN PATIENTS UNDER ANTIRETROVIRAL THERAPIES: FINDINGS FROM REAL-WORLD DATA IN ITALY

Trends in Discontinuation of Lipid-Lowering and Antihypertensive Therapies: A Real-World Data Analysis in Italy

Estimation of Patients with Psoriasis Potentially Eligible to Biologic Agents and Not Currently Treated with These Therapies: Analysis of Real-World Data in Italy